P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,602.70
68 (1.23%)
BSENSE

Nov 20

BSE+NSE Vol: 24.41 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 346859,
    "name": "P & G Health Ltd",
    "stock_name": "P & G Health Ltd",
    "full_name": "Procter & Gamble Health Ltd",
    "name_url": "stocks-analysis/p-g-health",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,602.70",
    "chg": 68,
    "chgp": "1.23%",
    "dir": 1,
    "prev_price": "5,534.70",
    "mcapval": "9,277.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500126,
    "symbol": "PGHL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE199A01012",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "24.41 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/p-g-health-346859-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Procter & Gamble Health Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/procter-amp-gamble-health-ltd-is-rated-sell-4260620",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ProcterGambleHe_mojoScore_4260620.png",
        "date": "2026-11-13 10:11:34",
        "description": "Procter & Gamble Health Ltd is rated Sell by MarketsMOJO, with this rating last updated on 04 September 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Procter & Gamble Health Declines 2.45% Despite Quarterly Gains: 2 Key Factors Behind the Slide",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/procter-gamble-health-declines-245-despite-quarterly-gains-2-key-factors-behind-the-slide-4256055",
        "imagepath": "",
        "date": "2026-11-08 09:00:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Stock opens at ₹5,815.15, up 2.30% on strong Sensex gains</p>\n                    <p><strong>3 Nov:</strong> Reports strong quarterly turnaround with record revenue and margin gains</p>\n                    <p><strong>4 Nov:</strong> Stock declines 2.54% despite Sensex gains, signalling profit-taking</p>\n                    <p><strong>5 Nov:</strong> Technical indicators turn bearish, stock falls 1.84%</p>\n                    <p><strong>6 Nov:</strong> Bearish momentum confirmed with downgrade; stock closes at ₹5,545.00</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</di..."
      },
      {
        "title": "Procter &amp; Gamble Health Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/procter-amp-gamble-health-ltd-is-rated-sell-4246456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ProcterGambleHe_mojoScore_4246456.png",
        "date": "2026-11-01 10:10:05",
        "description": "Procter &amp; Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Procter & Gamble Health Ltd Gains 12.95%: 4 Key Factors Driving the Weekly Surge",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/procter-gamble-health-ltd-gains-1295-4-key-factors-driving-the-weekly-surge-4246197",
        "imagepath": "",
        "date": "2026-11-01 09:00:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Week opens at Rs.5,054.20 with a modest 0.43% gain</p>\n                    <p><strong>27 Oct:</strong> Intraday high surge of 8.71%, closing at Rs.5,524.95 (+9.31%)</p>\n                    <p><strong>28 Oct:</strong> Technical momentum shift amid mixed signals, stock dips 2.33%</p>\n                    <p><strong>29 Oct:</strong> Bearish momentum confirmed with technical downgrade, price at Rs.5,396.05</p>\n                    <p><strong>30 Oct:</strong> Mildly bearish momentum with a 3.15% gain, closing at Rs.5,684.40</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div..."
      },
      {
        "title": "Procter & Gamble Health Ltd Sees Mixed Technical Signals Amid Mild Bearish Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/procter-gamble-health-ltd-sees-mixed-technical-signals-amid-mild-bearish-momentum-4243822",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ProcterGambleHe_technicaldot_4243822.png",
        "date": "2026-10-30 08:00:58",
        "description": "Procter & Gamble Health Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a 2.12% gain on 30 Oct 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, prompting a downgrade in its Mojo Grade from Hold to Sell."
      },
      {
        "title": "Procter & Gamble Health Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/procter-gamble-health-ltd-faces-bearish-momentum-amid-technical-downgrade-4242664",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ProcterGambleHe_technicaldot_4242664.png",
        "date": "2026-10-29 08:00:54",
        "description": "Procter &amp; Gamble Health Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating reflects deteriorating price action and weakening market sentiment, as evidenced by multiple technical parameters across daily, weekly, and monthly timeframes."
      },
      {
        "title": "Procter & Gamble Health Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/procter-gamble-health-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4241418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ProcterGambleHe_technicaldot_4241418.png",
        "date": "2026-10-28 08:01:52",
        "description": "Procter & Gamble Health Ltd has experienced a notable shift in price momentum, reflected in a 9.31% surge in its share price to ₹5,524.95 on 28 Oct 2026. Despite this strong daily gain, technical indicators present a nuanced picture, with a transition from bearish to mildly bearish trends and mixed signals across key metrics such as MACD, RSI, and moving averages. This analysis explores the implications of these technical developments for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Procter & Gamble Health Ltd Surges 8.7% to Day's High of Rs 5529.8 — Outperforms Sector by 8.15 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/procter-gamble-health-ltd-hits-intraday-high-with-871-surge-on-27-oct-2026-4241212",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ProcterGambleHe_priceRelatedfactors_4241212.png",
        "date": "2026-10-27 15:21:44",
        "description": "The Sensex edged down 0.07% on 27 Oct 2026, while Procter &amp; Gamble Health Ltd surged 8.71%, outperforming its Pharmaceuticals &amp; Biotechnology sector by over 8 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly subdued market environment."
      },
      {
        "title": "Procter & Gamble Health Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-4231874",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ProcterGambleHe_mojoScore_4231874.png",
        "date": "2026-10-21 10:10:02",
        "description": "Procter &amp; Gamble Health Ltd is rated Sell by MarketsMOJO. This rating was last updated on 04 September 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 21 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 73,
    "sid": "346859",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/procter-gamble-health-346859"
  },
  "announcements": [
    {
      "caption": " Intimation Regarding Ease Of Doing Investment - Special Window For Transfer And Dematerialization",
      "datetime": "17-Nov-2026",
      "details": "Stock Exchange is informed about an update on Ease of Investment - Special Window for Transfer and Dematerialization.",
      "source": "BSE"
    },
    {
      "caption": "Intimation For Change In Corporate Office Address Of Registrar And Share Transfer Agent (RTA)",
      "datetime": "13-Nov-2026",
      "details": "Intimation for Change in Corporate Office address of Registrar and Share Transfer Agent (RTA)",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Board Meeting For The Quarter Ended September",
      "datetime": "02-Nov-2026",
      "details": "",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Procter & Gamble Health Ltd has declared <strong>450%</strong> dividend, ex-date: 27 Aug 26",
          "dt": "2026-08-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Intimation Regarding Ease Of Doing Investment - Special Window For Transfer And Dematerialization

17-Nov-2026 | Source : BSE

Stock Exchange is informed about an update on Ease of Investment - Special Window for Transfer and Dematerialization.

Intimation For Change In Corporate Office Address Of Registrar And Share Transfer Agent (RTA)

13-Nov-2026 | Source : BSE

Intimation for Change in Corporate Office address of Registrar and Share Transfer Agent (RTA)

Outcome Of Board Meeting For The Quarter Ended September

02-Nov-2026 | Source : BSE

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Procter & Gamble Health Ltd has declared 450% dividend, ex-date: 27 Aug 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available